跳至主要内容
临床试验/NCT00804674
NCT00804674已完成2 期

Improved Pain Relief Using Intermittent Bupivacain Injections at the Donor Site After Breast Reconstruction With Deep Inferior Epigastric Artery Perforator (DIEP) Flap

Ullevaal University Hospital0 个研究点目标入组 47 人开始时间: 2005年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
47

研究概览

简要总结

patients are given bupivacain intermittent locally on the donor site after brest reconstruction with diep flap. The hypothesis was that this approach will reduce the need for rescue analgetic medication and pain perception within the three first days

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

性别
Female
接受健康志愿者

入选标准

  • all patients planned to undergo reconstructive breast surgery with a DIEP

排除标准

  • regular use of analgesics
  • known allergic reaction to bupivacain
  • bleeding disorders
  • pregnancy

研究组 & 干预措施

1 bupivacain

Active Comparator

干预措施: bupivacain (Drug)

2 placebo

Placebo Comparator

干预措施: placebo (Drug)

研究者

发起方
Ullevaal University Hospital
申办方类型
Other

相似试验